| 4.9 |
14.6 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 3.8 |
15.1 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 3.1 |
6.2 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 2.8 |
8.4 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 2.5 |
7.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.0 |
6.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.8 |
12.8 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 1.8 |
7.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.8 |
7.1 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 1.8 |
5.3 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.7 |
6.9 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 1.7 |
6.7 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.6 |
4.8 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 1.4 |
4.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.4 |
4.2 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 1.4 |
5.5 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 1.3 |
19.7 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 1.3 |
12.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 1.3 |
3.8 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 1.3 |
3.8 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 1.2 |
22.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 1.2 |
3.7 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 1.2 |
9.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.1 |
1.1 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 1.1 |
4.4 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.1 |
2.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.1 |
4.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.1 |
3.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 1.0 |
6.2 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.0 |
12.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 |
6.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.0 |
5.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.0 |
7.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.0 |
5.0 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 1.0 |
3.0 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.0 |
4.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.9 |
3.7 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.9 |
6.5 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
| 0.9 |
2.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.9 |
2.7 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.9 |
0.9 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.9 |
4.3 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.9 |
2.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.8 |
2.5 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.8 |
5.9 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.8 |
9.2 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.8 |
4.2 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.8 |
3.9 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.8 |
0.8 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.8 |
2.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.8 |
2.3 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.8 |
2.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.8 |
1.5 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.7 |
3.0 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.7 |
7.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.7 |
2.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.7 |
2.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.7 |
2.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.7 |
4.8 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.7 |
2.0 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.7 |
9.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.7 |
1.3 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 0.7 |
2.0 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.7 |
11.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.6 |
5.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.6 |
1.9 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.6 |
7.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.6 |
7.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 |
4.3 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.6 |
1.8 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.6 |
2.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.6 |
3.5 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.6 |
1.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.6 |
4.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.6 |
2.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.6 |
1.1 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.6 |
2.2 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.5 |
1.6 |
GO:0046959 |
habituation(GO:0046959) |
| 0.5 |
2.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) ATP transport(GO:0015867) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.5 |
3.7 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
1.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.5 |
1.6 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
1.0 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.5 |
3.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.5 |
1.6 |
GO:0042748 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.5 |
1.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.5 |
1.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.5 |
5.6 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.5 |
2.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) peptidyl-aspartic acid modification(GO:0018197) |
| 0.5 |
1.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.5 |
11.0 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.5 |
1.5 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.5 |
2.5 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.5 |
3.4 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.5 |
1.4 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.5 |
1.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
4.5 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.5 |
3.2 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
0.9 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.4 |
1.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 |
1.3 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.4 |
1.3 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
0.4 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.4 |
5.6 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 |
8.9 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.4 |
1.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.4 |
2.9 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.4 |
2.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.4 |
1.7 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.4 |
2.9 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.4 |
2.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.4 |
1.2 |
GO:0039521 |
suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.4 |
2.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.4 |
15.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 |
2.8 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.4 |
3.2 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.4 |
7.6 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.4 |
1.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.4 |
10.8 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 |
1.6 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.4 |
3.1 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.4 |
3.0 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.4 |
0.4 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.4 |
1.1 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.4 |
2.6 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.4 |
3.6 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.4 |
4.7 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.4 |
0.7 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.4 |
2.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.4 |
5.3 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.4 |
0.4 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.4 |
1.4 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.4 |
0.7 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.4 |
1.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
2.8 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.4 |
1.4 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.4 |
3.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 |
1.0 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.3 |
2.4 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.3 |
1.0 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.3 |
3.1 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.3 |
1.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
0.7 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.3 |
18.9 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.3 |
0.3 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.3 |
1.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.3 |
0.7 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.3 |
1.0 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.3 |
2.0 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.3 |
2.3 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
1.3 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 |
1.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
1.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
2.3 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.3 |
1.0 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.3 |
0.6 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.3 |
5.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.3 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.3 |
2.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
1.3 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.3 |
2.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
6.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.6 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.3 |
1.2 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.3 |
0.6 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 |
3.4 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.3 |
1.8 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.3 |
0.9 |
GO:0060024 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) rhythmic synaptic transmission(GO:0060024) acetylcholine secretion(GO:0061526) |
| 0.3 |
1.5 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
4.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.3 |
1.8 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.3 |
1.5 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
3.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.3 |
0.9 |
GO:1904154 |
trimming of terminal mannose on B branch(GO:0036509) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
1.7 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.3 |
3.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.3 |
2.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.3 |
0.8 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 |
0.8 |
GO:0009182 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.3 |
1.7 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.3 |
1.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
2.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 |
1.1 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
0.5 |
GO:0050859 |
B cell proliferation involved in immune response(GO:0002322) negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
1.4 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
1.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 |
3.4 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.3 |
0.5 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.3 |
0.3 |
GO:0071404 |
response to low-density lipoprotein particle(GO:0055098) cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.3 |
3.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.3 |
3.1 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 |
1.8 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
9.9 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.3 |
1.8 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.3 |
5.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.2 |
5.7 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.2 |
1.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
2.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.7 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.2 |
1.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
0.9 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 |
4.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
4.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 |
5.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
1.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
1.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.5 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
0.7 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 |
3.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.2 |
0.9 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 |
1.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.9 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
0.9 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.2 |
1.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.7 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 |
9.6 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.2 |
2.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.2 |
1.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
1.3 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
2.0 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
3.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.9 |
GO:1901160 |
serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
| 0.2 |
0.9 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
0.6 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.2 |
1.3 |
GO:0001996 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of heart rate by epinephrine(GO:0003065) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.2 |
1.5 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
1.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
1.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
0.6 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
1.0 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
0.2 |
GO:0001821 |
histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
0.6 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.2 |
1.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
0.6 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.8 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
0.6 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
3.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
1.2 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.2 |
0.8 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.2 |
2.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
1.2 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.6 |
GO:0001865 |
NK T cell differentiation(GO:0001865) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
0.6 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.2 |
1.5 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.2 |
0.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
0.4 |
GO:2000347 |
positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.2 |
0.6 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
2.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.2 |
3.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
0.6 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.2 |
0.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
6.8 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 |
0.2 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.2 |
1.3 |
GO:0035948 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 |
0.7 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.2 |
0.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) negative regulation of protein import into nucleus, translocation(GO:0033159) protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
1.6 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
0.7 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
5.5 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.7 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.2 |
0.9 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) |
| 0.2 |
1.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
0.7 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
2.7 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.2 |
0.7 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
1.7 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 |
1.5 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 |
0.3 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) regulation of cardiac cell fate specification(GO:2000043) |
| 0.2 |
2.8 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.2 |
0.7 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.2 |
0.5 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
0.5 |
GO:0000737 |
DNA catabolic process, endonucleolytic(GO:0000737) |
| 0.2 |
0.2 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.2 |
10.2 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 |
0.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.2 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.2 |
1.0 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.2 |
0.6 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.2 |
0.6 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.2 |
4.0 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.2 |
0.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.9 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
2.8 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.2 |
3.9 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
0.6 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 |
0.7 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
1.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
4.0 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.6 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
1.3 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
1.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
1.8 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
2.5 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
1.2 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
1.0 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
1.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.4 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.7 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
2.0 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.7 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.6 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
1.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
3.9 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.8 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.1 |
0.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
1.6 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
0.4 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
3.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
1.9 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
2.2 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.9 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
4.6 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.7 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
3.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.4 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.5 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.1 |
1.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
2.5 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
1.1 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.4 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.1 |
0.4 |
GO:0072102 |
glomerulus morphogenesis(GO:0072102) |
| 0.1 |
0.9 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
1.7 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.8 |
GO:0055021 |
regulation of cardiac muscle tissue growth(GO:0055021) |
| 0.1 |
0.8 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
2.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
1.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
5.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
1.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
2.0 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.5 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 |
0.2 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
4.0 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
1.1 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.6 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.2 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.6 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
1.0 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.4 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 |
0.3 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.7 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.1 |
1.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
1.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
1.5 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.1 |
11.4 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
10.2 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.1 |
0.3 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.1 |
0.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.6 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
2.0 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 |
0.4 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.2 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
0.2 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.0 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
1.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.5 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
1.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
1.3 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
1.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.6 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.2 |
GO:0060253 |
negative regulation of glial cell proliferation(GO:0060253) |
| 0.1 |
0.4 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
0.7 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
6.7 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
2.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.6 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
16.6 |
GO:0050890 |
cognition(GO:0050890) |
| 0.1 |
1.2 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.6 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.2 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.4 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.1 |
0.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
2.2 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.1 |
1.7 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
0.9 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.9 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.6 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.8 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.1 |
1.8 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
3.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
1.6 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.3 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
1.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.7 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
1.0 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.1 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.7 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 |
0.4 |
GO:0031398 |
positive regulation of protein ubiquitination(GO:0031398) |
| 0.1 |
0.1 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.1 |
0.9 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
1.1 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.1 |
0.3 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
0.4 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.4 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.8 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.1 |
1.0 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 |
0.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
1.2 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
3.5 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
0.4 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.8 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.3 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.9 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
1.1 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.4 |
GO:0046622 |
positive regulation of organ growth(GO:0046622) |
| 0.1 |
1.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
1.0 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
1.0 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
1.2 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
1.3 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.3 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
2.4 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.1 |
0.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
3.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.6 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.9 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.3 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.4 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
1.0 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.7 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.1 |
0.9 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.3 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.5 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.3 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
1.0 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.0 |
0.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.6 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.0 |
0.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.6 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
1.0 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 |
0.4 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.2 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.6 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.0 |
0.9 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
1.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
1.4 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
1.5 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.0 |
0.6 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
1.1 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
0.4 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 |
1.6 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.2 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.0 |
0.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.3 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
1.0 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.0 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.5 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
1.7 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.4 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.0 |
0.9 |
GO:0034341 |
response to interferon-gamma(GO:0034341) |
| 0.0 |
0.6 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.4 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.2 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 |
0.2 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.2 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.2 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.4 |
GO:0042761 |
very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.0 |
0.8 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
2.8 |
GO:0035304 |
regulation of protein dephosphorylation(GO:0035304) |
| 0.0 |
0.2 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 |
0.2 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.8 |
GO:0002793 |
positive regulation of peptide secretion(GO:0002793) |
| 0.0 |
0.5 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.4 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.4 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.1 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.5 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.2 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.0 |
0.5 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.1 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.1 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.2 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.3 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.0 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.5 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.0 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.6 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.1 |
GO:0050810 |
regulation of steroid biosynthetic process(GO:0050810) |
| 0.0 |
0.2 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.0 |
0.0 |
GO:1901018 |
positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
| 0.0 |
0.5 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.1 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.1 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.3 |
GO:0015992 |
proton transport(GO:0015992) |
